Valeo Pharma Inc (VPH.TO)
0.105
0.00 (0.00%)
CAD |
TSX |
May 17, 16:00
Valeo Pharma Total Assets (Quarterly): 40.35M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 40.35M |
October 31, 2023 | 41.21M |
July 31, 2023 | 45.54M |
April 30, 2023 | 48.36M |
January 31, 2023 | 47.79M |
October 31, 2022 | 58.26M |
July 31, 2022 | 66.91M |
April 30, 2022 | 24.41M |
January 31, 2022 | 29.84M |
October 31, 2021 | 21.03M |
July 31, 2021 | 26.22M |
Date | Value |
---|---|
April 30, 2021 | 18.85M |
January 31, 2021 | 9.173M |
October 31, 2020 | 10.96M |
July 31, 2020 | 7.097M |
April 30, 2020 | 7.071M |
January 31, 2020 | 6.406M |
October 31, 2019 | 5.807M |
July 31, 2019 | 6.164M |
April 30, 2019 | 3.208M |
January 31, 2019 | 3.625M |
October 31, 2018 | 3.385M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.807M
Minimum
Oct 2019
66.91M
Maximum
Jul 2022
27.45M
Average
24.41M
Median
Apr 2022
Total Assets (Quarterly) Benchmarks
Biocure Technology Inc | 1.976M |
Core One Labs Inc | 7.400M |
Nova Mentis Life Science Corp | 0.0539M |
Nanosphere Health Sciences Inc | 0.0238M |
Lobe Sciences Ltd | 2.109M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 87.37M |
Shareholders Equity (Quarterly) | -47.01M |
Debt to Equity Ratio | -1.369 |
Current Ratio | 0.4855 |
Net Debt Paydown Yield | -2.76% |